Immuneering Corp

Ownership Transactions Reported by 16 Insiders

Symbol
IMRX on Nasdaq
Location
245 Main Street, Second Floor, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10%+ Owner $9.65M Feb 5, 2025
Cormorant Asset Management, LP 10%+ Owner $8.6M Apr 1, 2024
Peter Feinberg Director $2.88M Jan 1, 2025
Brett Matthew Hall Chief Scientific Officer $2.69M Feb 5, 2025
Scott Barrett Chief Medical Officer $1.45M Feb 15, 2023
Michael Bookman Chief Legal Officer, Secretary $1.22M Feb 5, 2025
Biren Amin Cfo, Treasurer $934K May 12, 2022
Leah R. Neufeld Chief People Officer $815K Feb 5, 2025
Harold E. Brakewood Chief Business Officer $797K Feb 5, 2025
Ann E. Berman Director $428K Jan 1, 2025
Diana Hausman Director $228K Jun 12, 2024
Carpenter Robert J Director $228K Jun 12, 2024
Mallory Morales Chief Accounting Officer $216K Feb 5, 2025
Laurie Keating Director $89.4K Jan 1, 2025
Thomas J. Schall Director $7.39K Jun 12, 2024
Igor Matushansky Chief Medical Officer Mar 21, 2025

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.